BrickBio Announces Rapid V2, eCLIC™, Chemistry and Cytokine External Partner Collaboration

BOSTON, Nov. 2, 2021 /PRNewswire/ — BrickBio, the leader in site-specific bioconjugation, announced a rapid next-generation conjugation chemistry, eCLIC™ that will complement its existing high-performance chemistry, and may show significantly enhanced efficiency and scalability in a…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.